Anthony Hilton: Pension hitch to a deal for Smiths’ medical arm
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Yesterday brought reports that Smiths, one of our remaining powerful engineering groups, is wondering whether or not to sell its medical division, the unit which has been involved in many of the most significant advances in UK medical technology.
Smiths has a huge pension fund deficit and a workforce which is a mere fraction of what it was. The vast majority of the pension fund members whom the trustees exist to serve no longer have any connection with the group.
Thus the problem with any disposal is that it is likely to trigger a demand from the pension trustees that the proceeds be given to the fund to meet the obligations of the past, rather than reinvested in the business to meet the challenges of the future. If the medical division does go, the most interesting aspect of the sale will be how this dilemma is resolved.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments